ENTITY
Celgene Corp

Celgene Corp (CELG US)

78
Analysis
Health Care • United States
Celgene Corporation is a global biopharmaceutical company. The Company focuses on the discovery, development, and commercialization of therapies designed to treat cancer and immune-inflammatory related diseases.
more
•10 Mar 2019 09:17

Last Week in Event SPACE: MYOB, Lynas, Versum, Jardines

Last Week in Event SPACE ... Not a bad reward/risk as Manikay greenmails KKR's MYOB Group Ltd (MYO AU) offer. If the Malaysian government impasse...

Logo
570 Views
Share
•07 Mar 2019 12:30•Syndicated

Bristol Myers Squib & Celgene–Starboard Objections Addressed Today- Successful Deal Closure Probable

The proposed Bristol Myers Squibb Co (BMY US) & Celgene Corp (CELG US) transaction announced in the first week of 2019, garnered many sceptical...

Logo
420 Views
Share
bullish•Celgene Corp
•28 Feb 2019 16:28

M&A: A Round-Up of Deals in February 2019

For the month of February, thirteen new deals were discussed on Smartkarma with an overall deal size of US$12.3bn. This overall number includes the...

Logo
919 Views
Share
bullish•Celgene Corp
•01 Feb 2019 15:21

M&A: A Round-Up of Deals in January 2019

For the month of January, seventeen new deals were discussed on Smartkarma with an overall deal size of US$91bn, with ~81% of that figure from the...

Logo
1.3k Views
Share
•27 Jan 2019 09:18

Last Week in Event SPACE: Renault/Nissan, Bank Danamon, Kabu, Celgene, Intouch

Last Week in Event SPACE ... The eventual unwind of tension may involve an increase in Nissan Motor (7201 JP)'s stake in Renault SA (RNO FP) and a...

Logo
1.1k Views
Share
x